Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

NCT06648889 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

T-ALL

Interventions

DRUG: Isatuximab
DRUG: Isatuximab

Sponsor

Goethe University

Collaborators

[object Object]